
Lagos Life maker bags $500k in just 24 hours
Vatar’s quick cash haul rivals the buzz around the Dangote IPO
Follow the technologies reshaping finance, healthcare and business, from AI and robotics deals to the platforms powering the next wave of innovation.

Vatar’s quick cash haul rivals the buzz around the Dangote IPO

The Nigerian-made Lagos Life browser game is turning viral attention into real advertising revenue inside its first week.

Apple’s single-bank launch barely scratches a UPI-dominated market

Analysts call the 16% slide an overreaction to the Bluevine deal.

Six interlocking engines power Apple’s run toward a $5 trillion valuation.

Ionis stands to earn up to $400M after Roche’s kidney drug clears Phase 3.

Novo’s CagriSema beat a low dose of Lilly’s tirzepatide on 21 September, but investors sold on 2030 ambitions that pitch the drugmaker as an ordinary-growth pharma

Medtronic’s robotic platform now has its vessel-sealing tool in the US, but the procedures it can actually perform there haven’t changed yet.

J&J sold its $400 million Laminar program, narrowing competition for Boston Scientific and Abbott in LAA closure.

Stablecoin card spending hit $4.5B in 2025, but the real constraint on new programs is daily settlement funding, not deman

Beta Bionics could shift up to $10M to 2027 as customers await its new patch pump.
Newsletter
One email every Sunday. The week’s most useful guides, market-moving stories, and practical tools — chosen by our editors.